Opthea (OPT) Stock Highlights

3.28 | +0.61%

2024-11-21 04:17:48

Opthea Ltd operates in one industry being the medical technology and healthcare. It is focused primarily on developing biological therapeutics for eye diseases. The company is developing a novel biologic therapy, OPT-302, for the treatment of eye diseases. Its products are based on the intellectual property portfolio covering Vascular Endothelial Growth Factors C and D and R3 targets. Optheas development activities are based on an intellectual property portfolio covering key targets Vascular Endothelial Growth Factors VEGF-C, VEGF-D and VEGF Receptor-3 for the treatment of diseases associated with blood and lymphatic vessel growth, as well as vascular leakage.

Statistics

Range Today

3.26 3.37

Volume Today 19.7K

Range 1 Year

1.79 5.45

Volume 1 Year 6.64M

Range 3 Year

1.6 8.5

Volume 3 Year 9.47M

Range 10 Year

1.6 16.23

Volume 10 Year 22.22M

Highlights

Market Capitalization 669.85M (small)

Floating Shares 773.18M

Current Price 3.28

Price To Earnings -1.49

Price To Revenue 19.43K

Earnings Per Share -2.76

Payout Ratio 0%

Performance

Latest +0.61%

1 Month -35.18%

3 Months +21.93%

6 Months -2.09%

1 Year +72.63%

3 Years -51.62%

5 Years -70.32%

10 Years -70.32%

Benchmarks

Market Capitalization

202 / 368

Gross Profits

143 / 278

Total Revenue

256 / 300

Total Rank

343 / 368

Free Cashflow

269 / 352

Performance 5 years

210 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.